Cargando…
A randomized phase 2 clinical trial of phentolamine mesylate eye drops in patients with severe night vision disturbances
PURPOSE: Dim light vision disturbances (DLD) comprise a wide range of symptoms affecting the quality of vision at low illumination including glare, halos, and starbursts. This exploratory study investigated 1.0% phentolamine mesylate ophthalmic solution (PMOS) as a treatment to improve vision and im...
Autores principales: | Pepose, Jay, Brigell, Mitchell, Lazar, Eliot, Heisel, Curtis, Yousif, Jonah, Rahmani, Kavon, Kolli, Ajay, Hwang, Min, Mitrano, Cara, Lazar, Audrey, Charizanis, Konstantinos, Sooch, Mina, McDonald, Marguerite |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9548101/ https://www.ncbi.nlm.nih.gov/pubmed/36209072 http://dx.doi.org/10.1186/s12886-022-02621-6 |
Ejemplares similares
-
Phentolamine Mesylate Ophthalmic Solution Provides Lasting Pupil Modulation and Improves Near Visual Acuity in Presbyopic Glaucoma Patients in a Randomized Phase 2b Clinical Trial
por: Pepose, Jay S, et al.
Publicado: (2021) -
APE1/Ref-1 as a Novel Target for Retinal Diseases
por: Heisel, Curtis, et al.
Publicado: (2021) -
Oral phentolamine mesylate in the treatment of complex regional pain syndrome.
por: McCleane, G. J.
Publicado: (1996) -
Efficacy of phentolamine mesylate in reducing the duration of various local anesthetics
por: Gago-García, Alejandro, et al.
Publicado: (2021) -
Phentolamine mesylate can alleviate the nausea and vomiting associated with liver metastasis.
por: McCleane, G. J.
Publicado: (1996)